These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37585381)

  • 1. A physiologically based pharmacokinetic model to optimize the dosage regimen and withdrawal time of cefquinome in pigs.
    Mi K; Sun L; Hou Y; Cai X; Zhou K; Ma W; Xu X; Pan Y; Liu Z; Huang L
    PLoS Comput Biol; 2023 Aug; 19(8):e1011331. PubMed ID: 37585381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model.
    Zhang L; Wu X; Huang Z; Zhang N; Wu Y; Cai Q; Shen X; Ding H
    Vet Microbiol; 2018 Jun; 219():100-106. PubMed ID: 29778180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals.
    Lee DH; Birhanu BT; Lee EB; Lee SJ; Boby N; Park YS; Park SC
    Vet Res; 2020 Oct; 51(1):131. PubMed ID: 33059768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.
    Gu M; Zhang N; Zhang L; Xiong M; Yang Y; Gu X; Shen X; Ding H
    BMC Vet Res; 2015 Jul; 11():169. PubMed ID: 26209108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of a population physiologically based pharmacokinetic model for penicillin G in swine and cattle for food safety assessment.
    Li M; Gehring R; Riviere JE; Lin Z
    Food Chem Toxicol; 2017 Sep; 107(Pt A):74-87. PubMed ID: 28627373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus).
    Zhao DH; Wang XF; Wang Q; Li LD
    BMC Vet Res; 2017 Jul; 13(1):226. PubMed ID: 28754112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model.
    Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H
    J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli.
    Xiao X; Chen X; Yan K; Jiang L; Li R; Liu Y; Wang M; Wang Z
    J Vet Pharmacol Ther; 2022 Jan; 45(1):83-91. PubMed ID: 34469000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a single intramuscular injection of cefquinome in buffalo calves.
    Venkatachalam D; Dumka VK; Ranjan B
    J Vet Pharmacol Ther; 2018 Feb; 41(1):155-158. PubMed ID: 28891215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Monte Carlo analysis within a physiologically based pharmacokinetic model to predict doxycycline residue withdrawal time in edible tissues in swine.
    Yang F; Liu HW; Li M; Ding HZ; Huang XH; Zeng ZL
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(1):73-84. PubMed ID: 22059524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis.
    Xiao X; Sun J; Chen Y; Huang RJ; Huang T; Qiao GG; Zhou YF; Liu YH
    BMC Vet Res; 2015 Feb; 11():33. PubMed ID: 25889187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics and pharmacokinetic/pharmacodynamic analysis by nonlinear mixed-effects modeling of cefquinome in nonpregnant, pregnant, and lactating goats after intravenous and intramuscular administration.
    Litterio NJ; Lorenzutti AM; Zarazaga MDP; Himelfarb MA; San Andrés-Larrea MI; Serrano-Rodríguez JM
    J Vet Pharmacol Ther; 2021 Jan; 44(1):68-78. PubMed ID: 32779241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and synovial fluid pharmacokinetics of cefquinome following the administration of multiple doses in horses.
    Uney K; Altan F; Altan S; Erol H; Arican M; Elmas M
    J Vet Pharmacol Ther; 2017 Jun; 40(3):239-247. PubMed ID: 27641837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial disposition in pulmonary epithelial lining fluid of horses, part III. cefquinome.
    Winther L; Baptiste KE; Friis C
    J Vet Pharmacol Ther; 2011 Oct; 34(5):482-6. PubMed ID: 21083664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of Susceptibility Breakpoint for Cefquinome against
    Mi K; Li M; Sun L; Hou Y; Zhou K; Hao H; Pan Y; Liu Z; Xie C; Huang L
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439008
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation and evaluation of cefquinome-loaded gelatin microspheres and the pharmacokinetics in pigs.
    Zhang S; Dai W; Lu Z; Lei Z; Yang B; He B; Zhou H; Cao J
    J Vet Pharmacol Ther; 2018 Feb; 41(1):117-124. PubMed ID: 28656695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of residue depletion of cyadox and its marker residue in edible tissues of pigs using physiologically based pharmacokinetic modelling.
    Huang L; Lin Z; Zhou X; Zhu M; Gehring R; Riviere JE; Yuan Z
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2015; 32(12):2002-17. PubMed ID: 26414219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection.
    Wang J; Shan Q; Ding H; Liang C; Zeng Z
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3008-12. PubMed ID: 24614373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against
    Zhang L; Zhou Z; Gu X; Huang S; Shen X; Ding H
    Front Vet Sci; 2020; 7():448. PubMed ID: 32851028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
    Limbert M; Isert D; Klesel N; Markus A; Seeger K; Seibert G; Schrinner E
    Antimicrob Agents Chemother; 1991 Jan; 35(1):14-9. PubMed ID: 2014969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.